- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 744-758 of
1,261 results
1304 Exhibit: Exhibit 1304 Schwartzbard Decl
Document
IPR2023-00724, No. 1304 Exhibit - Exhibit 1304 Schwartzbard Decl (P.T.A.B. May. 22, 2024)
|
|
Cite Document
2461 Exhibit: EX2461 Qtern Prescribing Information rev Feb 2017
Document
IPR2023-00724, No. 2461 Exhibit - EX2461 Qtern Prescribing Information rev Feb 2017 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2415 Exhibit: EX2415 US Food Drug Administration, DrugsFDA, Tradjenta®
Document
IPR2023-00724, No. 2415 Exhibit - EX2415 US Food Drug Administration, DrugsFDA, Tradjenta® (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2462 Exhibit: EX2462 US Food Drug Administration, DrugsFDA, Qtern
Document
IPR2023-00724, No. 2462 Exhibit - EX2462 US Food Drug Administration, DrugsFDA, Qtern (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2536 Exhibit: EX2536 Partial Transcript of July 22, 2024 Conference Call
Document
IPR2023-00724, No. 2536 Exhibit - EX2536 Partial Transcript of July 22, 2024 Conference Call (P.T.A.B. Jul. 25, 2024)
|
|
Cite Document
1143 Exhibit: Exhibit 1143 James
Document
IPR2023-00724, No. 1143 Exhibit - Exhibit 1143 James (P.T.A.B. May. 22, 2024)
|
|
Cite Document
1185 Exhibit: Exhibit 1185 Track Drugs
Document
IPR2023-00724, No. 1185 Exhibit - Exhibit 1185 Track Drugs (P.T.A.B. May. 22, 2024)
|
|
Cite Document
1110 Exhibit: Exhibit 1110 Karagiannis
Document
IPR2023-00724, No. 1110 Exhibit - Exhibit 1110 Karagiannis (P.T.A.B. May. 22, 2024)
|
|
Cite Document
2385 Exhibit: EX2385 Wilding, JPH, The importance of weight management in type ...
Document
IPR2023-00724, No. 2385 Exhibit - EX2385 Wilding, JPH, The importance of weight management in type 2 diabetes mellitus, Int J Clin Pract, 2014 Jun 686682 691 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
... PhD Regarding Inva lidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 122...
Document
IPR2023-00724, No. 2551 Exhibit - EX2551 Opening Expert Report of William J Jusko, PhD Regarding Inva lidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 122 cv 03038
|
|
Cite Document
2653 Exhibit: EX2653 July 8, 2024 Email Thread Among Counsel for Petitioners My...
Document
IPR2023-00724, No. 2653 Exhibit - EX2653 July 8, 2024 Email Thread Among Counsel for Petitioners Mylan, DRL, and Sun, and Counsel for Novo Regarding IPR2023 00724 – Service of draft p...
|
|
Cite Document
1048 Exhibit: FDA Exposure Response 2003
Document
IPR2023-00724, No. 1048 Exhibit - FDA Exposure Response 2003 (P.T.A.B. Mar. 16, 2023)
|
|
Cite Document
1054 Exhibit: Landersdorfer 2011a
Document
IPR2023-00724, No. 1054 Exhibit - Landersdorfer 2011a (P.T.A.B. Mar. 16, 2023)
|
|
Cite Document
1063 Exhibit: Kirillova 2012
Document
IPR2023-00724, No. 1063 Exhibit - Kirillova 2012 (P.T.A.B. Mar. 16, 2023)
|
|
Cite Document
2550 Exhibit: EX2550 Sun Pharmaceutical Industries Ltd’s and Sun Pharmaceutic...
Document
IPR2023-00724, No. 2550 Exhibit - EX2550 Sun Pharmaceutical Industries Ltd’s and Sun Pharmaceutical In dustries Inc’s Stipulation of Invalidity Contentions, In re Ozempic Semaglutide Pate...
|
|
Cite Document
